The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal, announced that...
A Two-part Phase I Study With the Antibody-drug Conjugate SYD985 in Combination With Niraparib to Evaluate Safety, Pharm...
AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biopharmaceutical company aiming to democratize R&D ...
Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...
Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...
South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...
US based Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the di...
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Av...
BellaSeno GmbH, an ISO 13485-certified clinical-stage medtech company developing absorbable scaffolds using additiv...
The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacifi...
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivot...
Swedish firm Lipidor AB has announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical compan...
Alterity Therapeutics announced that it has received guidance from the US Food and Drug Administration (FDA) in relation...
Panthera and Rutherford Health plc have entered a collaboration to create a network of world-class clinical trial sites ...
The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea’s world-class 1,...
Government Medical College and Hospital (GMCH) of Nagpur, Maharastra, India, will serve as the lead site for the “...
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital on 10 June 2020 that Australia current...
The Australian CRO, Avance Clinical, said there was a 34% increase in the number of international trials registered in A...
